Professor Tassos Karadimitris to head myeloma research centre at Imperial
Professor Tassos Karadimitris has been appointed as Langmuir Chair and Director of the Hugh and Josseline Langmuir Centre for Myeloma Research.
Cancer-causing HTLV-1 virus hijacks cellular machinery to establish infection
Scientists have used a cutting-edge visualisation technique to show how the human T-cell lymphotropic virus, type 1 (HTLV-1) infects immune cells.
New Riffyn-Imperial partnership set to accelerate synthetic biology research
A new open-science collaboration will establish a digital backbone for synthetic biology research and education in scientific reproducibility.
Faulty genes and misguided antibodies underlie life-threatening COVID-19
New research has shed light on why some people develop a more severe form of COVID-19 than others.
Feature
“It’s been devastating”: How COVID-19 is impacting Alzheimer’s research and care
Alzheimer’s researcher Dr Ashwin Venkataraman shares first-hand insights into how the COVID-19 pandemic has affected patients and ongoing research.
Potential therapeutic targets for cancer-causing virus uncovered by new research
Scientists have discovered key factors that control the genome maintenance and replication of a virus responsible for a rare form of cancer.
Feature
T cell immunity: What is it and how does it help to protect us from COVID-19?
Over the past few months, you’ll have heard a lot about the importance of antibodies and how they can help us to understand our immunity to COVID-19.
12
New scholarships scheme announced in memory of Professor Jackie de Belleroche
New scholarships for postgraduate neuroscience students will celebrate the life of Professor Jackie de Belleroche, who passed away in July 2019.
Feature
Why you don’t need to worry about the bubonic plague
Reports of bubonic plague in Inner Mongolia earlier this week have attracted a significant amount of media attention.
Professor José Penadés appointed as new Director of the MRC CMBI
Professor José Penadés has been appointed as Director of the MRC Centre for Molecular Bacteriology and Infection (CMBI), commencing 1 July 2020.
